• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cygene Laboratories Inc


Ticker Delisted

Snapshot for Cygene Laboratories Inc (CYGE)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for CYGE

No chart data available.
  • 1M
  • 1Y
Interactive CYGE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYGE

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0930
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 58.02
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYGE

No data available

Company Profile & Key Executives for CYGE

CyGene Laboratories Inc. is seeking to market commercialized genetic testing to the public. The Company develops proprietary and automated DNA and RNA testing systems for the screening, monitoring, and diagnosis of human, veterinary, and plant diseases. CyGene's primary development focus is blood screening tests for the West Nile Virus and the detection of biological warfare agents.

Martin MunzerPresident/CEOBarry H DvorchikVP:Drug Development
Peter J LaurenceVP:Business DevelopmentJeffrey PincoDirector:Laboratory
More Company Profile & Key Executives for CYGE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil